This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization